Proteomics

Dataset Information

0

Nuclear Cx43 interactome LC-MSMS


ABSTRACT: Our research provides a robust rationale for the clinical investigation of Cx43 as a therapeutic target with the potential to enhance the efficacy of existing treatments, prevent the emergence of drug resistance, and address the key limitation of current targeted therapies.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Malignant Cell

DISEASE(S): Melanoma

SUBMITTER: Susana Bravo  

LAB HEAD: Susana B Bravo López

PROVIDER: PXD053555 | Pride | 2026-02-09

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
A375_C_1.wiff Wiff
A375_C_1.wiff.scan Wiff
A375_C_1_FDR.xlsx Xlsx
A375_C_2.wiff Wiff
A375_C_2.wiff.scan Wiff
Items per page:
1 - 5 of 19
altmetric image

Publications


BRAF and MEK inhibitors (BRAF/MEKi) have radically changed the treatment landscape of advanced BRAF mutation-positive tumours. However, limited efficacy and emergence of drug resistance are major barriers for successful treatments. Here, by using relevant preclinical models, we find that Connexin43 (Cx43), a protein that plays a role in cell-to-cell communication, enhances the effectiveness of BRAF/MEKi by recruiting DNA repair complexes to lamin-associated domains and promoting persistent DNA d  ...[more]

Similar Datasets

2016-08-24 | E-GEOD-85968 | biostudies-arrayexpress
2018-10-24 | PXD008036 | Pride
2016-08-09 | PXD003683 | Pride
2025-06-04 | PXD061688 | Pride
2025-06-04 | PXD056238 | Pride
2025-09-24 | GSE304422 | GEO
2023-08-23 | PXD038378 | Pride
2020-11-05 | PXD021679 | Pride
2015-09-09 | PXD002331 | Pride
2024-08-12 | PXD042059 | Pride